2023
Articles
Artico, J. et al. (2023) Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation, 147(5), pp. 364-374. (doi: 10.1161/CIRCULATIONAHA.122.060632) (PMID:36705028) (PMCID:PMC9889203)
Bhandari, S. et al. (2023) Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes. Journal of Nephrology, (doi: 10.1007/s40620-023-01571-6) (PMID:36995528) (PMCID:PMC10061401) (Early Online Publication)
Böhm, M., Abdin, A., Slawik, J., Mahfoud, F., Borer, J., Ford, I. , Swedberg, K., Tavazzi, L., Batailler, C. and Komajda, M. (2023) Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, (doi: 10.1002/ejhf.2870) (PMID:37092340) (Early Online Publication)
Broadway, K. A. et al. (2023) Loci for insulin processing and secretion provide insight into type 2 diabetes risk. American Journal of Human Genetics, 110(2), pp. 284-299. (doi: 10.1016/j.ajhg.2023.01.002) (PMID:36693378)
Cassidy, S. et al. (2023) Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT). Diabetic Medicine, 40(3), e15010. (doi: 10.1111/dme.15010) (PMID:36398460)
Cleland, J. G.F. , Pellicori, P. and Graham, F. J. (2023) Redefining both iron deficiency and anaemia in cardiovascular disease. European Heart Journal, (doi: 10.1093/eurheartj/ehad154) (PMID:36879446) (Early Online Publication)
Dawson, J. et al. (2023) Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial. EClinicalMedicine, 57, 101863. (doi: 10.1016/j.eclinm.2023.101863)
Docherty, K. F. et al. (2023) Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B ‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. European Journal of Heart Failure, 25(2), pp. 248-259. (doi: 10.1002/ejhf.2763) (PMID:36597719)
Ferreira, J. P. et al. (2023) Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials. European Journal of Heart Failure, 25(1), pp. 108-113. (doi: 10.1002/ejhf.2726) (PMID:36303266)
Ford, I. and Kalra, P. R. (2023) Unanswered questions from the IRONMAN trial - authors' reply. Lancet, 401(10387), pp. 1495-1496. (doi: 10.1016/S0140-6736(23)00448-8) (PMID:37149301)
Graham, F., Iaconelli, A., Sonecki, P., Campbell, R. T., Hunter, D., Cleland, J. G.F. and Pellicori, P. (2023) Defining Heart Failure Based on Imaging the heart and beyond. Cardiac Failure Review, (Accepted for Publication)
Graham, F. J., Friday, J. M., Pellicori, P. , Greenlaw, N. and Cleland, J. G.F. (2023) Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. Heart, (doi: 10.1136/heartjnl-2022-322145) (PMID:37130747) (Early Online Publication)
Graham, F. J., Pellicori, P. , Kalra, P. R., Ford, I. , Bruzzese, D. and Cleland, J. G.F. (2023) Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. European Journal of Heart Failure, (doi: 10.1002/ejhf.2810) (PMID:36823953) (Early Online Publication)
Hlatky, M. A. et al. (2023) Randomized comparison of chest pain evaluation with FFRCT or standard care: factors determining US costs. Journal of Cardiovascular Computed Tomography, 17(1), pp. 52-59. (doi: 10.1016/j.jcct.2022.09.005) (PMID:36216700)
Inciardi, R., Pellicori, P. and Chandra, A. (2023) Identification and quantification of congestion in heart failure: a work in progress. European Journal of Heart Failure, 25(1), pp. 61-62. (doi: 10.1002/ejhf.2751) (PMID:36464796)
Jäger, M., Zangger, G., Bricca, A., Dideriksen, M., Smith, S. M., Midtgaard, J., Taylor, R. S. and Skou, S. T. (2023) Mapping interventional components and behaviour change techniques used to promote self-management in people with multimorbidity: a scoping review. Health Psychology Review, (doi: 10.1080/17437199.2023.2182813) (PMID:36811829) (Early Online Publication)
Kenny, E., Coyne, R., McEvoy, J. W., McSharry, J., Taylor, R. S. and Byrne, M. (2023) Behaviour change techniques and intervention characteristics in digital cardiac rehabilitation: a systematic review and meta-analysis of randomised controlled trials. Health Psychology Review, (doi: 10.1080/17437199.2023.2185653) (PMID:36892523) (Early Online Publication)
Lee, S. I. et al. (2023) Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK. BMJ Open, 13(2), e068718. (doi: 10.1136/bmjopen-2022-068718) (PMID:36828655) (PMCID:PMC9972454)
MacBeth, A., Mcskimming, P., Bhattacharya, S., Park, J., Gumley, A. , St Clair, D. and Berry, S. J.E. (2023) General and age-specific fertility rates in non-affective psychosis: population-based analysis of Scottish women. Social Psychiatry and Psychiatric Epidemiology, 58(1), pp. 105-112. (doi: 10.1007/s00127-022-02313-y) (PMID:35648175) (PMCID:PMC9845143)
Mooney, L., Jackson, C. E., Adamson, C., McConnachie, A. , Welsh, P. , Myles, R. C. , McMurray, J. J.V. , Jhund, P. S. , Petrie, M. C. and Lang, N. N. (2023) Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction. Circulation: Heart Failure, (doi: 10.1161/CIRCHEARTFAILURE.122.010051) (PMID:36896709) (Early Online Publication)
Nuzzi, V. et al. (2023) Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications. Clinical Research in Cardiology, 112(3), pp. 419-430. (doi: 10.1007/s00392-022-02126-8) (PMID:36385396) (PMCID:PMC9998319)
Ouwerkerk, W. et al. (2023) Association of time‐to‐IV ‐furosemide with mortality in acute heart failure: data from REPORT‐HF. European Journal of Heart Failure, 25(1), pp. 43-51. (doi: 10.1002/ejhf.2708) (PMID:36196060)
Petrie, M. C. et al. (2023) High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. Cardiovascular Research, 119(1), pp. 213-220. (doi: 10.1093/cvr/cvab317) (PMID:34875022) (PMCID:PMC10022850)
Purcell, C. , Purvis, A., Cleland, J. G.F. , Cowie, A., Dalal, H. M., Ibbotson, T. , Murphy, C. and Taylor, R. S. (2023) Home-based cardiac rehabilitation for people with heart failure and their caregivers: a mixed-methods analysis of the roll out an evidence-based programme in Scotland (SCOT:REACH-HF study). European Journal of Cardiovascular Nursing, (doi: 10.1093/eurjcn/zvad004) (PMID:36617216) (Early Online Publication)
Robb, K. A. et al. (2023) Increasing uptake of FIT colorectal screening: protocol for the TEMPO randomised controlled trial testing a suggested deadline and a planning tool. BMJ Open, 13(5), e066136. (doi: 10.1136/bmjopen-2022-066136)
Rotbain Curovic, V. et al. (2023) Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – a post-hoc analysis of the PRIORITY randomized clinical trial. Journal of Diabetes and its Complications, 37(4), 108433. (doi: 10.1016/j.jdiacomp.2023.108433) (PMID:36841085)
Savarese, G., von Haehling, S., Butler, J., Cleland, J. G.F. , Ponikowski, P. and Anker, S. D. (2023) Iron deficiency and cardiovascular disease. European Heart Journal, 44(1), pp. 14-27. (doi: 10.1093/eurheartj/ehac569) (PMID:36282723) (PMCID:PMC9805408)
Subramanian, A. et al. (2023) Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. BMC Medicine, 21, 21. (doi: 10.1186/s12916-022-02722-5) (PMID:36647047) (PMCID:PMC9843951)
Sullivan, M. K. et al. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73(727), e141-e147. (doi: 10.3399/BJGP.2022.0145) (PMID:36376072) (PMCID:PMC9678375)
Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)
Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal - Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (Early Online Publication)
Tun, H. N., Khan, H., Chernikova, D., Mareev, Y., Chakrabarti, S., Thant, M. and Cannata, A. (2023) Conduction system pacing: promoting the physiology to prevent heart failure. Heart Failure Reviews, 28(2), pp. 379-386. (doi: 10.1007/s10741-023-10296-4) (PMID:36781809)
van der Klaauw, A. A. et al. (2023) Accelerated waning of the humoral response to COVID-19 vaccines in obesity. Nature Medicine, 29(5), pp. 1146-1154. (doi: 10.1038/s41591-023-02343-2) (PMID:37169862) (PMCID:PMC10202802)
Vidal-Petiot, E., Elbez, Y., Mesnier, J., Ducrocq, G., Ford, I. , Tendera, M., Ferrari, R., Tardif, J.-C., Fox, K. M. and Steg, P. G. (2023) Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. European Journal of Preventive Cardiology, (doi: 10.1093/eurjpc/zwad004) (PMID:36617264) (Early Online Publication)
Walker-Bone, K., Macfarlane, G. J., Burton, K., McConnachie, A. M. , Zhang, R. and Jones, G. T. (2023) Advice to remain active with arm pain reduces disability. Occupational Medicine, (Accepted for Publication)
Wang, H. et al. (2023) Cardiovascular safety in type 2 diabetes with sulfonylureas as second-line drugs: a nation-wide population-based comparative safety study. Diabetes Care, (doi: 10.2337/dc22-1238) (PMID:36944118) (Early Online Publication)
Whinnett, Z. I. et al. (2023) Effects of haemodynamically atrio‐ventricular optimized His‐pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) randomised, double‐blind, cross‐over trial. European Journal of Heart Failure, 25(2), pp. 274-283. (doi: 10.1002/ejhf.2736) (PMID:36404397)
Wu, X. et al. (2023) [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nature Medicine, 29(1), pp. 190-202. (doi: 10.1038/s41591-022-02114-5) (PMID:36646800)
Young, W. J. et al. (2023) Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease. Nature Communications, 14, 1411. (doi: 10.1038/s41467-023-36997-w)